Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Defining Success With Antiretroviral Therapy

Defining Success With Antiretroviral Therapy Influence of the Timing of Antiretroviral Therapy Original Investigation Research of the Collaboration of Observational HIV subjects receiving antiretroviral therapy. J Acquir activation and smaller HIV reservoir size. J Infect Dis. Epidemiological Research Europe (COHERE) study Immune Defic Syndr. 2011;57(5):387-395. 2013;208(8):1202-1211. in EuroCOORD. The incidence of AIDS-defining 20. Writing Committee for the CASCADE 29. Hocqueloux L, Avettand-Fènoël V, Jacquot S, illnesses at a current CD4 count200 cells/μL in Collaboration. Timing of HAART initiation and et al; AC32 (Coordinated Action on HIV Reservoirs) the post-combination antiretroviral therapy era. clinical outcomes in human immunodeficiency virus of the Agence Nationale de Recherches sur le Sida Clin Infect Dis. 2013;57(7):1038-1047. type 1 seroconverters. Arch Intern Med. 2011;171 et les Hépatites Virales (ANRS). Long-term 13. Marin B, Thiébaut R, Bucher HC, et al. (17):1560-1569. antiretroviral therapy initiated during primary HIV-1 Non–AIDS-defining deaths and immunodeficiency infection is key to achieving both low HIV reservoirs 21. Shepherd BE, Jenkins CA, Rebeiro PF, et al. in the era of combination antiretroviral therapy. AIDS. and normal T cell counts. J Antimicrob Chemother. Estimating the optimal CD4 count for HIV-infected 2009;23(13):1743-1753. 2013;68(5):1169-1178. persons to start antiretroviral therapy. Epidemiology. 14. Wilson EM, Sereti I. Immune restoration after 2010;21(5):698-705. 30. Cohen http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Defining Success With Antiretroviral Therapy

JAMA Internal Medicine , Volume 175 (1) – Jan 1, 2015

Loading next page...
 
/lp/american-medical-association/defining-success-with-antiretroviral-therapy-20YSs5ardE
Publisher
American Medical Association
Copyright
Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2014.4004
pmid
25419970
Publisher site
See Article on Publisher Site

Abstract

Influence of the Timing of Antiretroviral Therapy Original Investigation Research of the Collaboration of Observational HIV subjects receiving antiretroviral therapy. J Acquir activation and smaller HIV reservoir size. J Infect Dis. Epidemiological Research Europe (COHERE) study Immune Defic Syndr. 2011;57(5):387-395. 2013;208(8):1202-1211. in EuroCOORD. The incidence of AIDS-defining 20. Writing Committee for the CASCADE 29. Hocqueloux L, Avettand-Fènoël V, Jacquot S, illnesses at a current CD4 count200 cells/μL in Collaboration. Timing of HAART initiation and et al; AC32 (Coordinated Action on HIV Reservoirs) the post-combination antiretroviral therapy era. clinical outcomes in human immunodeficiency virus of the Agence Nationale de Recherches sur le Sida Clin Infect Dis. 2013;57(7):1038-1047. type 1 seroconverters. Arch Intern Med. 2011;171 et les Hépatites Virales (ANRS). Long-term 13. Marin B, Thiébaut R, Bucher HC, et al. (17):1560-1569. antiretroviral therapy initiated during primary HIV-1 Non–AIDS-defining deaths and immunodeficiency infection is key to achieving both low HIV reservoirs 21. Shepherd BE, Jenkins CA, Rebeiro PF, et al. in the era of combination antiretroviral therapy. AIDS. and normal T cell counts. J Antimicrob Chemother. Estimating the optimal CD4 count for HIV-infected 2009;23(13):1743-1753. 2013;68(5):1169-1178. persons to start antiretroviral therapy. Epidemiology. 14. Wilson EM, Sereti I. Immune restoration after 2010;21(5):698-705. 30. Cohen

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Jan 1, 2015

References